InvestorsHub Logo
Followers 229
Posts 14785
Boards Moderated 1
Alias Born 03/29/2014

Re: Doktornolittle post# 467369

Saturday, 05/07/2022 11:10:17 AM

Saturday, May 07, 2022 11:10:17 AM

Post# of 709412
Good to see that you’re back with us Doktornolittle!

I’m not sure if you’re thinking that the new end points intend to compare all patients who received DCVax (so treatment and part of the control arm… early and late) to an external control arm (ECA)… but if so, that’s not the case. They’ll be comparing the treatment arm (early) to the ECA. Then the control arm that did receive DCVax (late) will be compared to a recurrent GBM control arm.

What I really like about this is that everyone’s data is used. I would like to think that is of some consolation to the families of those in the trial who are no longer alive.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News